Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01418352Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Aug 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Aug 2011; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT01418352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01418352.